Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

09:04 AM
Last (IDR):

PT Bifarma Adiluhung, a subsidiary of PT Kalbe Farma, Tbk launched ReGeniC (Regenerative and Cellular Therapy)    Submit now Ristek-Kalbe Science Awards 2014 - appreciation for best researcher in Indonesia   Kalbe announced the Company’s indicative performance (unaudited) reached Rp 16.01 Trillion, increase 17.% compared to last year.